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Cell-penetrating peptideparticularly micelles and liposomes equipped with uptake-mediating address
compounds, have attracted much attention as pharmaceutical formulations. Their development requires an
understanding of the mechanism by which the carrier systems interact with and translocate into the target
cells. We developed an apolipoprotein E-derived peptide, called A2, that efﬁciently translocates across cell
membranes. Upon coupling of two palmitoyl chains (P2), the highly cationic sequence acquires detergent-
like properties such as a strong tendency to self-associate and the ability to integrate into lipid bilayers.
Confocal laser scanning microscopy and ﬂuorescence activated cell sorting were used to compare the
internalization of the ﬂuorescence-labeled monomeric A2 with the uptake of the colloidal P2A2 micelles and
P2A2-tagged liposomes into endothelial cells of blood vessels. Speciﬁc inhibitors of endocytosis were used to
identify the underlying mechanisms. b.End3 and BAEC cells as example of endothelial cells of small
capillaries and large vascular vessels, respectively, were examined. The uptake of monomeric A2 was
characterized by poor cellular selectivity. A2 was efﬁciently internalized into both cell lines via at least two
different mechanisms. Besides an endocytotic uptake route, a second passive pathway exists, that leads to a
rapid distribution of A2 within the cytoplasm. Also liposomes tagged with P2A2 were non-selectively
internalized into both b.End3 and BAEC cells. Their nonselective uptake was mediated by clathrin- and
caveolin-independent endocytosis. In contrast, micellar P2A2 entered b.End3 cells via clathrin-mediated
endocytosis, while no uptake of P2A2 into BAEC cells was observed. In conclusion, the speciﬁc clathrin-
mediated uptake mode of P2A2 micelles might provide the basis for a blood brain barrier-speciﬁc targeting.
© 2008 Elsevier B.V. All rights reserved.1. Introduction
A prerequisite for successful application of all bioactive agents is
the access to their site of action. For agents with intracellular targets
the transmembrane transport can constitute a major obstacle.
Especially large, hydrophilic molecules tend to have poor pharmaco-
kinetics and cannot cross the plasma membrane [1]. One approach to
overcome these limitations is the incorporation into or attachment to
molecular carriers, e.g. liposomes ormicelles [2]. Their properties such
as vesicle size, surface charge density, and sterical stability can easily
be adapted to meet variable requirements and thus to increase their
range of application [3]. However, the potential advantages of carrier
administration are often limited by a low speciﬁcity. A favorable
method to overcome this problem is the derivatization of the carrier
with target-recognizing and uptake-mediating ligands [4]. One
possibility is the application of so called cell-penetrating peptides
(CPPs), which can facilitate the transport of attached cargos across the
cellular barrier. So far themechanism of CPP internalization is not well
understood and reports are often conﬂicting [5]. Earlier studies49 30 94793159.
ll rights reserved.proposed a receptor- and energy-independent mechanism [6,7]
whereas more recently, also active endocytotic mechanisms have
been proposed [8,9]. In some cases, the internalization depends on
strong ionic interactions between the positively charged peptides and
negatively charged constituents of the cell surface such as heparan
sulfate proteoglycanes (HSPGs) [10,11]. Cargos delivered by CPPs are
very diverse in size and structure. They range from small molecules
like biotin or doxorubicin [12] and peptides [13] up to large proteins
[14] and liposomes [15,16]. It is reasonable to assume an inﬂuence of
the cargo on the internalization process. For the TAT peptide, derived
from the transactivator of transcription protein of HIV-1 [17], trans-
duction as main entry process has been reported whereas endocytosis
becomes predominant with increasing size of attached cargos [18].
Attempts to characterize such relations in detail are scarce so far.
A peptide exhibiting certain characteristics of CPPs is A2 (LRK LRK
RLLR)2, a tandem dimer derived from the low density lipoprotein-
receptor (LDLr) binding-domain of apolipoprotein E (141–150)2. The
sequence comprises binding sites for the LDLr [19,20] as well as for
cell-surface HSPGs [21,22]. Covalently coupled, A2 mediates an
efﬁcient internalization of sterically stabilized liposomes into primary
rat brain capillary endothelial cells [16]. N-terminal dipalmitoylation
(P2) confers surfactant-like properties upon the cationic A2. The
Fig. 1. Sequences of apolipoprotein E peptides in one-letter amino acid code. All
peptides are C-terminally amidated. fA2 (MW: 3098.2 g/mol) is labeled with
carboxyﬂuorescein at the N-terminus via a glycine linker. P2A2 (MW: 3530.9 g/mol)
is equipped with a short N-terminal linker sequence and palmitoylated at the N-
terminal tryptophan and the side chain of lysine at position 2. P2fA2 (MW: 4019.3 g/
mol) is equipped with a short N-terminal linker sequence. The two palmitoyl chains are
linked to the N-terminal lysine and carboxyﬂuorescein is coupled to the side chain of
lysine at position 3.
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liposomes [23,24]. Both colloidal systems efﬁciently translocate across
the membrane of brain capillary endothelial cells. Studies with P2A2-
tagged liposomes containing ﬂuorescein isothiocyanate-dextran as
ﬂuorescent probe in the aqueous liposomal lumen suggest that the
liposomes are internalized intact [24,25].
Different pinocytotic mechanisms mediate the entry of particulate
structures into mammalian cells [26]. Large systems can be inter-
nalized by macropinocytosis or membrane rufﬂing [26]. The well
characterized clathrin-mediated endocytosis (CME) is crucial for many
cellular processes, among others the uptake of essential nutrients or
transferrin and LDL via receptor binding [27]. Another endocytotic
process is based on caveolae which are abundant in endothelial cells
where they constitute 10–20% of the cell surface. The uptake of serum
albumins, for instance, is mediated by receptors localized in caveolae
[28]. Another pinocytic mechanism is merely described as non-
clathrin and non-caveolin-dependent. So far this mode of cellular
uptake is poorly understood and most likely more than one
mechanism is involved. The various uptake modes result in endocy-
totic vesicles with different properties [26]. As the mode of
transmembrane transport determines the intracellular fate of mole-
cules and colloidal systems [29,30], our interest has been focused
upon the elucidation of the mechanism of uptake of the different A2
formulations. Different pharmacological inhibitors were used to
analyse the endocytotic pathways. As endocytosis is based on the
activity of the cytoskeleton, application of the F-actin-depolymerizing
drug cytochalasin D results in a blockade of all endocytotic processes
[31,32]. Chlorpromazine prevents the formation of clathrin lattices at
the plasma membrane and thus efﬁciently inhibits CME [33].
Caveolar-mediated endocytosis, which is characterized by the assem-
bly of caveolin in the plasmamembrane, is blocked by the cholesterol-
complexing drug nystatin [34].
Endothelial cells of the blood vessels constitute the ﬁrst contact
area of intravenously applied drug formulations. To assess the
transmembrane transport properties of cells lining blood capillaries
and large vessels, we compared the uptake of the monomeric A2
peptide, small P2A2 micelles and P2A2-tagged large liposomes into
brain capillary endothelial cells (b.End3) [35,36] and aortic endothelial
cells (BAEC) [37].
2. Materials and methods
2.1. Materials
Protected amino acids were purchased from GLS (Shanghai, China)
or Novabiochem (Darmstadt, Germany). Palmitic acid, other chemi-
cals, and solvents used for peptide synthesis were from Fluka (Buchs,
Switzerland). The lipids 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-
choline (POPC) and 1,2-dipalmitoyl-sn-glycero-3-phosphoethanola-
mine-N-[lissamine rhodamine B sulfonyl] (ammonium salt) (Rhod-
DPPE) were obtained fromAvanti Polar Lipids (Alabaster, USA). Calcein
was from Fluka (Deisenhofen, Germany). The tissue-culturemedia and
ﬂuorescein-conjugated transferrin were from Gibco®/Invitrogen™
(Carlsbad, USA). (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl)tetrazo-
lium bromide (MTT) was purchased from Sigma (Munich, Germany).
2.2. Peptide synthesis and characterization
The peptides were synthesized on solid phase (TentaGel-S-RAM;
Rapp Polymere, Tuebingen, Germany) using an ABI 433A automatic
peptide synthesizer (Applied Biosystems, Foster City, USA) following
the standard Fmoc (9-ﬂuorenylmethoxycarbonyl) chemistry protocol
[38,39]. The tandem repeat A2 (141–150)2 was N-terminally modiﬁed
with carboxyﬂuorescein (f). The carboxyﬂuorescein labeled peptide
P2fA2 was synthesized using a Fmoc-lysine(Dde) derivative (Nα-(9-
ﬂuorenylmethoxycarbonyl)-Nɛ-1-(4,4-dimethyl-2,6-dioxocyclohex-1-ylidene)ethyl-L-lysine) and a Fmoc-lysine(Fmoc) derivative (Nα-(9-
ﬂuorenylmethoxy-carbonyl)-Nɛ-(9-ﬂuorenylmethoxycarbonyl)-L-
lysine) at the N-terminus [16,23]. Acylation of A2 and fA2 was
performed overnight with a 10-fold excess of palmitic acid activated
with diisopropylcarbodiimide/N-hydroxybenzotriazole. Subsequently
the Dde group was cleaved off with 2% hydrazine in dimethyl
formamide for 10 min and carboxyﬂuorescein was coupled with
diisopropylcarbodiimide/N-hydroxybenzotriazole at a 4-fold excess
overnight. Cleavage from the resin with 10% phenol in triﬂuoroacetic
acid (TFA) for 3 h gave the C-terminally amidated peptides.
Puriﬁcation was carried out by preparative reverse phase high-
performance liquid chromatography (RP-HPLC) using a LC-8A system
(Shimadzu, Kyoto, Japan) with a PLRP-S 10 μm column (Polymer
Laboratories, Amherst, USA). A purity better than 95% was achieved as
determined by analytical RP-HPLC on a LC-2010C system (Shimadzu,
Kyoto, Japan) using a Prontosil 300-5-C18 column (Bischoff, Leonberg,
Germany).
The peptides were further characterized by matrix-assisted laser
desorption ionization time-of-ﬂight mass spectrometry (MALDI-TOF)
on a Voyager-DESTR (Applied Biosystems, Foster City, USA) to conﬁrm
the expected masses.
2.3. Particle preparation
Micelles instantly form by self-association [23] when lyophilized
P2A2/P2fA2 is dissolved in Dulbecco's phosphate buffered saline, pH
7.4, supplemented with 1 g/l D-glucose (DPBSG).
Large and small unilamellar vesicles (LUVs and SUVs, respectively)
were prepared as described previously [24]. In short, dry POPC ﬁlms
were suspended in DPBSG by vortexing and SUVs and LUVs were
produced by subsequent soniﬁcation or 35-times extrusion through
two stacked polycarbonate ﬁlters with 100 nm pores using a
MiniExtruder (Avestin, Ottawa, Canada), respectively. For ﬂow cyto-
metric measurements POPC-LUVs with 0.1% Rhod-DPPE were pre-
pared. P2fA2- or P2A2-liposome complexes were prepared by mixing
both components at appropriate concentrations.
2.4. Particle characterization
The liposome size was checked by dynamic light scattering (DLS)
on a N4 Plus particle sizer (Beckman Coulter, Fullerton, USA).
Liposomal integrity was determined in a dye release experiment.
Aliquots of POPC-LUV suspensions with internally trapped calcein at
self-quenching concentration (80mM in 10mMTris, 0.1mM EDTA, pH
7.4) were injected into cuvettes containing 2.5 ml stirred peptide
solutions (varying peptide concentrations in 10 mM Tris, 154 mM
NaCl, 0.1 mM EDTA, pH 7.4). The ﬁnal lipid concentration was 25 μM.
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measuring the increase in ﬂuorescence intensity (λex=490 nm,
λem=520 nm) after 5 min at room temperature on a LS 50B
spectroﬂuorimeter (Perkin Elmer, Waltham, USA). The ﬂuorescence
intensity corresponding to 0% and 100% release was measured in the
absence of peptide and after addition of Triton X-100 (100 μl, 10% v/v
in water), respectively. The Cl/p of half maximal dye release was
determined from dose–response curves by a sigmoid ﬁt using Sigma
Plot (Systat Software, San Jose, USA).
Fluorescence spectra of the carboxyﬂuorescein-labeled peptides
fA2, P2fA2, and P2fA2-LUV complexes(λex=488 nm, λem=500–
600 nm) in DPBS were recorded using a FP-6500 ﬂuorescence
spectrometer (Jasco, Tokyo, Japan).
2.5. Cell culture
Immortalized mouse brain endothelial cells (b.End3) (ECACC
96091929) [35,36] and bovine aortic endothelial cells (BAEC) [37]
were cultured in Earle's minimal essential medium (E-MEM)
supplemented with 10% fetal bovine serum (FBS), 2 mM N-acetyl-L-
alanyl-L-glutamine, 100 U/ml penicillin, and 100 U/ml streptomycin at
37 °C in a humidiﬁed atmosphere of 5% CO2.
2.6. Toxicity test
Cell viability was determined using the MTT method [40,41]. A
total of 2.5×104 cells per well were seeded 24 h prior to the
experiment in a 96-well plate. The cells were exposed to increasing
concentrations of A2 peptides or A2 peptide-labeled liposomes in
DPBSG for 30 min at 37 °C. Cells treated with DPBSG referred to as
100% viable. Afterwards the cells were incubated in 180 μl E-MEM and
20 μl of 5 mg/ml 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazo-
liumbromide (MTT) in DPBS per well for 4 h at 37 °C. The mediumwas
removed and 100 μl dimethylsulfoxide was added per well. The
absorption at 550 nm was measured using a Saﬁre microplate reader
(Tecan, Zurich, Switzerland). Cell viability was determined by normal-
izing the signals to 100% and plotted against peptide concentrations.
2.7. Confocal-laser-scanning microscopy (CLSM)
CLSM was employed in order to monitor the uptake of the A2
formulations and to determine their intracellular location. Cells were
plated on poly-L-lysine-coated cover slips (diameter 30 mm) posi-
tioned in 35 mm plastic culture dishes and cultured for one day. The
exponentially growing cells were washed with DPBSG and exposed to
different A2-formulations and/or transferrin in DPBSG for 1 h. After
washing two times with ice-cold DPBSG, cells were kept on ice until
CLSM pictures were taken.
The cell vitality was checked by trypanblue exculsion. One drop of
0.5% trypanblue in PBS was put onto the surface of the microscopic
sample.
CLSM pictures were taken using an LSM 510 inverted confocal laser
scanning microscope equipped with a Plan-Neoﬂuar 100×/1.3 oil
objective (Carl Zeiss, Oberkochen, Germany). For carboxyﬂuorescein
labeled samples, excitation was performed using a 200 mW argon
laser (488 nm) at 10% intensity and emission was registered using a
BP505–530 bandpass ﬁlter. Trypanblue was excited at 633 nm with a
15mWhelium-neon laser (633 nm) at 30% intensity and emissionwas
recorded using a LP650 cutoff ﬁlter. The pinhole was set to 300 μm.
Image acquisition was done sequentially to minimize cross-talk
between the ﬂuorophores.
2.8. Flow cytometry (FACS)
To investigate the internalization of different A2 formulations,
exponentially growing adherent cells were washed with DPBSG at37 °C and then incubated with peptides for 1 h at 37 °C (see ﬁgure
legends for concentrations). In order to reduce the ﬂuorescence of
surface-bound peptide and detach the cells, they were washed two
times with ice cold DPBSG and incubated for 5 min with 1 ml of 0.1%
pronase E in DPBS with 0.5mMEDTA at 4 °C. The reactionwas stopped
byadding 0.7ml of 1% BSA inDPBS. The cell suspensionwas centrifuged
for 4 min at 4500 ×g and 4 °C. The cell pellet was kept on ice until the
measurement was performed. Immediately before the analysis the
cells were resuspended in ice cold 0.5–1.0 ml 1% BSA in DPBS
(depending on the cell density) and 8 μl 0.5% trypanblue per 0.5 ml
volume was added to further reduce extra cellular ﬂuorescence [42].
To examine the mechanism of internalization, a pre-incubation
step with endocytosis inhibitors was introduced followed by co-
incubation of the samples and the respective inhibitor. Pre incubation
and uptake studies were performed for 1 h at 37 °C with 2 mg/ml
cytochalasin D, 10 mg/ml chlorpromazine, or 25 mg/ml nystatin,
respectively, in DPBSG.
Fluorescence analysis was performed using a FACSCalibur ﬂuores-
cence-activated cell sorter (BD Biosciences, Franklin Lakes, USA) using
a 530/30 nm bandpass ﬁlter (FL1) for carboxyﬂuorescein/ ﬂuorescein
with 500 V detector voltage for fA2 and 550 V for P2fA2 and
ﬂuorescein-conjugated transferrin incubated samples. A 585/42 nm
bandpass ﬁlter (FL2) with 550 V detector voltage was used for
rhodamine labeled samples. Viable cells for analysis were gated by dot
plots. The respective scatter characteristics were determined before by
backward-gating of propidium iodide negative cells. A minimum of
10,000 events per sample was analyzed. Each experiment was
performed at least twice in duplicates or triplicates.
3. Results
3.1. Characterization of A2, micellar, and liposomal peptide complexes
The apoE-derived peptides used in this study are shown in Fig. 1.
The biophysical properties of the peptides and P2A2-liposome
complexes have been described previously [23,24]. Monomeric A2
shows only weak interaction with neutral POPC lipid bilayers
[19,24,43]. The dipalmitoylated peptide P2A2 forms micelles in
aqueous solution with a Stokes radius of 5.3 nm. The molecular
mass of 68,000 g/mol, determined by analytical ultracentrifugation,
corresponds to 19 P2A2 molecules per micelle [23]. The peptide-
surface density is 5.38×10−4 P2A2/Å2. At a molar lipid to peptide ratio
Cl/p of 1000 binding of P2A2 and P2fA2 to preformed POPC LUVswith a
diameter of 100 nm had no signiﬁcant inﬂuence upon the size
distribution. Dye release experiments with P2A2 and liposomal
trapped calcein yielded a half-maximal dye release at a Cl/p of 450
(Fig. 2A). Thus, at a Cl/p of 1000 the liposomal integrity was not
affected. The number of surface-located P2A2 molecules was
calculated to be 100, corresponding to a peptide-surface density of
3.18×10−5 P2A2/Å2.
In Fig. 2B the carboxyﬂuorescein ﬂuorescence spectra of mono-
meric fA2, micellar P2fA2, and liposomal-bound P2fA2 recorded at
identical concentration are presented. Micellar P2fA2 showed a strong
decrease in intensity to about 33% compared to fA2. This reﬂects
presumably a self-quenching effect of carboxyﬂuorescein in the
micellar structure. Binding to POPC-SUVs at a Cl/p of 1000 results in
a partial restoration of ﬂuorescence, reaching 80% of the intensity
observed for monomeric fA2.
3.2. Toxicity
The viability of both b.End3 and BAEC cells in the presence of
monomeric fA2, micellar P2fA2, and liposomes tagged with P2A2 at a
Cl/p of 1000 is presented in Fig. 3. Pure POPC-liposomes show minor
toxicity, as the cell viability remains over 80% at lipid concentrations
up to 7.5 mM (data not shown).
Fig. 2. (A) Liposomal integrity was determined by monitoring the increase in
ﬂuorescence after dilution of POPC-LUVs with internally trapped calcein at self-
quenching concentration in stirred P2A2 solutions. Fluorescence intensity was
measured at λex=490 nm and λem=520 nm after 5 min at room temperature. The
ﬂuorescence intensity corresponding to 0% was measured in absence of peptide and
100% release was determined after the addition of Triton X-100 for each sample.
Liposomal integrity [%] was calculated by normalizing the resulting ﬂuorescence
intensity to the 100% signal and plotted against the corresponding lipid to peptide ratios
(Cl/p). The Cl/p of half-maximal dye release was determined from dose–response curves
by sigmoid ﬁtting. (B) Fluorescence spectra of fA2, P2fA2, and P2fA2 in presence of POPC
SUVs (Cl/p=1000) in DPBS. Peptide concentration is 0.5 μM for all peptides. The
ﬂuorescence was excitated at 488 nm.
Fig. 3. Viability of (A) mouse brain capillary endothelial cells (b.End3) and (B) bovine
aortic endothelial cells (BAEC) exposed to increasing concentrations of the peptides fA2
(●), P2fA2(○), and of P2fA2-liposome complexes (▾) with a Cl/p of 1000.
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low up to 10 μM peptide concentrations (Fig. 3A). At 1 μM fA2 and
liposomal bound P2fA2 the viability of b.End3 cells is 90%, at 1 μM
micellar P2fA2 it is still 75%.
BAEC cells show a more distinct susceptibility to the toxic effect of
fA2 (Fig. 3B). Up to 1 μM fA2 and micellar P2fA2 nearly no toxic effect
was observed. Above 1 μM a strong decrease in cell survival is seen,
resulting in 20% viability at 10 μM peptide concentration. Liposomal
bound P2fA2 has a considerably higher concentration-dependent
toxicity. At 1 and 10 μM the cell viability was found to be 50% and 20%,
respectively.
3.3. Cellular uptake (CLSM)
Monomeric fA2 is efﬁciently internalized into b.End3 and BAEC
cells. CLSM studies with fA2 at 37 °C reveal a vesicular
intracellular ﬂuorescence superimposed by an evenly distributed
cytosolic ﬂuorescence in both cell lines (Fig. 4A). The contribution
of both ﬂuorescence patterns to the overall ﬂuorescence is highly
variable. Additionally, as the cytosolic ﬂuorescence is still observed
at 4 °C, while active uptake mechanisms are blocked or at least
considerably decreased, a second, non-active mechanism must bepostulated for the internalization of fA2. The integrity of the
plasma membrane was untouched as assayed by trypanblue
exclusion.
Also liposomes tagged with P2fA2 are rapidly internalized into
both b.End3 and BAEC cells at 37 °C into cytoplasmic vesicles (Fig. 4B).
At 4 °C no intracellular ﬂuorescence was observed. Both observations
suggest endocytosis as internalization mechanism.
Cell incubation with micellar P2fA2 at 37 °C lead to a strong
vesicular ﬂuorescence in b.End3 cells whereas the uptake into BAEC
was drastically reduced (Fig. 4C). As the uptake into b.End 3 cells is
blocked at low temperature, an endocytotic process is suggested. The
striking difference in the internalization of P2fA2 micelles into brain
capillary and aortic endothelial cells led to the assumption that
different uptake mechanisms were addressed.
3.4. Uptake mechanism (FACS)
Fluorescent activated cell sorting (FACS) was used in order to
quantify the inhibitory effect of cytochalasin D, chlorpromazine, and
nystatin on the cellular uptake of the different A2 peptide formulations.
Cells incubated with fA2 revealed high variance in the ﬂuorescent
intensities (Fig. 5A). At 4 °C CLSM studies showed little active uptake
and only the evenly distributed cellular ﬂuorescence contributed to
the signal. The FACS results showed cells with highly diverse
ﬂuorescence intensity. Hence, the mean ﬂuorescence intensities
observed in cells show high standard deviations.
b.End3 and BAEC cells incubated at 37 °C with liposomes
ﬂuorescently labeled with rhodamine-DPPE and targeted with P2A2
revealed high ﬂuorescent intensities (Fig. 5B). Cytochalasin D
Fig. 5. FACS analysis of mouse brain capillary endothelial cells (b.End3, black) and
bovine aortic endothelial cells (BAEC, white) exposed for 1 h to (A) 2 μM fA2 (FL1, 500 V
detector voltage), (B) 1 µM P2A2 and 0.1% Rhodamine-DPPE POPC liposomes (Cl/p of
1000, FL2, 550 V detector voltage), or (C) 1 μM P2fA2 (FL1, 550 V detector voltage) at
37 °C, 4 °C, in presence of 2 mg/ml cytochalasin D, 10 mg/ml chlorpromazine, or 25 mg/
ml nystatin. Cells for analysis were gated by scatter plots and a minimum of 10,000
events per sample was analyzed. Each experiment was performed at least twice in
duplicates or triplicates. Means±standard deviation are indicated. Values signiﬁcantly
(pb0.05) different from control (internalization at 37 °C) as determined by Student's t-
test are marked with asterisk.
Fig. 4. CLSM images of mouse brain capillary endothelial cells (b.End3, right) and bovine
aortic endothelial cells (BAEC, left) exposed to (A) 2 μM fA2, (B) 1 μM P2fA2-POPC
liposome complexes (Cl/p of 1000), or (C) 1 μM P2fA2 at 37 °C or 4 °C. One drop of 0.5%
trypanblue in PBS was carefully put onto the surface of the microscopic sample. The red
ﬂuorescence of trypanblue on the cell membrane documents the viability of the cells.
Pictures were taken after incubation for 1 h.
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while chlorpromazine and nystatin had no effect. These observations
point to non-clathrin, non-caveolin-mediated endocytosis as major
uptake route for peptide-tagged liposomes.Fig. 5C conﬁrms that P2fA2 micelles were efﬁciently internalized
into b.End3 cells when incubated at 37 °C. Cytochalasin D and
chlorpromazine efﬁciently blocked this uptake, while nystatin had no
effect. In contrast, the uptake of micelles into BAEC cells was very low
and modiﬁcation of the incubation conditions had little inﬂuence.
These ﬁndings are consistent with results of CLSM studies performed
under the same conditions (data not shown). The results imply, that
micellar P2fA2 enters b.End3 cells via a clathrin-mediated endocytotic
uptake route, which is not active or at least strongly reduced in BAEC
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mediated endocytosis or the absence of speciﬁc uptake mediating
structures for micellar P2fA2, we examined the uptake of transferrin
into BAEC cells as an example for clathrin-mediated endocytosis [44].
3.5. Uptake of transferrin (FACS)
FACS studies showed efﬁcient internalization of transferrin into
b.End3 cells at 37 °C, which is inhibited at 4 °C and in the presence of
cytochalasin D and signiﬁcantly reduced by chlorpromazine (Fig. 6).
This conﬁrms the existence of clathrin-mediated endocytosis in
b.End3 cells. The uptake of transferrin in BAEC at 37 °C cells is reduced
compared to b.End3 cells. At 4 °C and the presence of cytochalasin D
the signal is further decreased but the effect of chlorpromazine was not
signiﬁcant. This is indicative of an endocytotic mechanism, that is not
dependent on clathrin.
4. Discussion
Although the application of micelles and liposomes to overcome
cellular boundaries is highly favorable, the speciﬁcity and uptake of
the high molecular weight carriers is poor in most cells. As shown in
this study, the membrane-translocating sequence A2 mediates the
cellular uptake of both particles. The uptake is unspeciﬁc for
liposomes, but cell-selective for peptide micelles and mediated by
different endocytotic mechanisms.
Monomeric fA2 is readily taken up into endothelial cells of brain
capillaries (b.End3) as well as of large blood vessels (BAEC) by at least
two functionally different mechanisms. The vesicular ﬂuorescence is
blocked at low temperature pointing to an endocytotic mechanism,
while the cytosolic ﬂuorescence observed even at low temperature
proves the existence of a second non-active internalization mechan-
ism. As an escape of fA2 from the vesicles can be ruled out and the
integrity of the plasma membrane is conserved as assayed by
trypanblue exclusion, the cytosolic ﬂuorescence is no artefact as
observed in earlier CPP studies, where the diffuse ﬂuorescence pattern
was caused by redistribution upon cell ﬁxation [45]. Similar observa-
tions have been made with the TAT peptide and mouse myoblasts [18]
and with penetratin, nona-arginine (R9) and TATon HeLa cells [5]. The
underlying processes of the rapid internalization referred to as
transduction are still in question. However, formation of membrane-
soluble ion pair complexes with negatively charged membraneFig. 6. FACS analysis of mouse brain capillary endothelial cells (b.End3, black) and
bovine aortic endothelial cells (BAEC, white) exposed for 1 h to 250 nM transferrin (FL1,
550 V detector voltage) at 37 °C, 4 °C, in presence of 2 mg/ml cytochalasin D, 10 mg/ml
chlorpromazine, or 25 mg/ml nystatin. Cells for analysis were gated by scatter plots and
aminimum of 10,000 events per samplewas analyzed. Each experiment was performed
at least twice in duplicates or triplicates. Means±standard deviation are indicated.
Values signiﬁcantly (pb0.05) different from the control (internalization at 37 °C) as
determined by Student's t-test are marked with asterisk.constituents and a subsequent internalization driven by the trans-
membrane potential may play a role [11,46,47].
Incubation of b.End3 and BAEC cells with P2fA2-tagged liposomes
resulted exclusively in strong vesicular ﬂuorescence, which is blocked
at low temperature. This clearly points to an endocytotic uptake
mechanism, which is not cell selective. A shift of the internalization
mechanism to endocytosis has also been observed for TAT and
penetratin upon coupling to proteins or liposomes [18,48]. In contrast
to fA2 and peptide liposome complexes, micellar P2fA2 showed
distinct cell selectivity. P2fA2 micelles entered b.End3 cells in an
endocytotic manner, whereas the uptake into BAEC cells was found to
be low.
The striking difference in the extent of micellar and liposomal
internalization prompted us to examine the underlying endocytotic
mechanisms. P2fA2-tagged liposomeswere found to be internalizedby
an endocytotic process that was independent of clathrin and caveolin
in both cell lines. In difference to liposomes, P2fA2 micelles are
internalized into b.End3 cells via clathrin-dependent endocytosis as
the internalization was signiﬁcantly decreased by cytochalasin D and
chlorpromazine. A mono-stearylated octa-arginine has been found to
enterNIH/3T3-cells in the sameway [49]. Though the structurewas not
examined in detail, one might expect that the lipidated oligo-arginine
organizes in a similar micellar structure as P2fA2.
The intriguing mechanistic switch observed between the mono-
meric and particulate peptides may be related either to the size
difference between micelles and liposomes and/or the different
peptide densities on the surface. Micellar P2fA2 is characterized by a
peptide-surface density of 5.38×10−4 P2A2/Å2,while liposomes tagged
with P2fA2 have a more than 10 times lower peptide-surface density
of 3.18×10−5 P2A2/Å2.
The different characteristics may lead to selective interactions with
cell surface HSPGs and subsequent activation of different uptake
mechanisms. Ligand-induced clustering of syndecans, an HSPG class
with type I transmembrane core proteins, enhances the rate of
endocytosis [50]. An increase in endocytotic activity is suggested upon
presentation of multivalent ligands [51]. P2A2 tagged particles might
act in the same way. While the internalization of lipoproteins via the
LDLr in a clathrin-dependent manner is well known, syndecans have
been shown to mediate the clathrin-independent endocytosis of
lipoproteins and apoE-VLDL bound to lipoprotein lipase [50].
Whereas the internalization of A2 tagged sterical stabilized
liposomes into human ﬁbroblasts is LDLr-independent [16], it is
conceivable that the high local concentration of ligands as seen in
P2fA2micellesmay increase the afﬁnity for the LDLr because of avidity
effects. It has been shown, that the high afﬁnity of apoE-containing
lipoproteins to the LDLr results from the potential to form multiple
interactions with the receptor [52]. However, the cellular structures
which mediate binding and trigger the subsequent internalization of
micellar P2fA2 remain to be elucidated.
The inﬂuence of the endocytosis inhibitors upon the P2fA2 uptake
into BAEC is low and little differentiated, which can be related to the
generally low uptake of P2fA2 micelles. To test the existence of
clathrin-mediated endocytosis in these cells, we compared the uptake
of transferrin in both cell lines. The internalization of transferrin is
widely accepted as a classical example for clathrin-mediated endocy-
tosis [44]. FACS studies show efﬁcient internalization of transferrin
into b.End3 cells, which is inhibited in the presence of cytochalasin D
and signiﬁcantly reduced by chlorpromazine. This is not only a proof
for the activity of the used inhibitors but also conﬁrms the existence of
clathrin-mediated endocytosis. The uptake of transferrin in BAEC cells
was reduced compared to b.End3 cells and the effect of chlorproma-
zine was not signiﬁcant. This denotes that the observed preferance of
P2A2 micelles for b.End3 cells may be attributed to a general
deﬁciency of clathrin-mediated endocytosis in BAEC cells.
No involvement of caveolae in the internalization of monomeric
fA2, P2fA2 micelles or liposomes tagged with P2A2 was observed
448 E. Leupold et al. / Biochimica et Biophysica Acta 1788 (2009) 442–449although the expression of caveolinwas shown for b.End3 cells [36] as
well as for BAEC cells [53] and a caveolin-mediated uptake of TAT
fusion proteins in HeLa cells has been reported [54,55].
In summary, our results show that not only the uptake mediating
compound, but also the structure of the carrier mediates target
speciﬁcity and affects the route of cellular uptake. Free monomeric fA2
is taken up by at least two functionally different mechanisms. Besides
an endocytotic route, a second non-active pathway exists, which leads
to a rapid distribution of fA2 into the cytoplasm. The uptake of carriers
tagged with A2 is mediated by endocytotic processes. However, the
involved cellular structures are different. While micellar P2fA2 is
internalized selectively by capillary endothelial cells via clathrin-
mediated endocytosis, the uptake of liposomes tagged with P2fA2
seems tobenot cell-speciﬁc and is clathrin- and caveolin-independent.
The efﬁcient internalizationofmicellar P2fA2 into capillary endothelial
cells but low uptake into endothelial cells of large vessels may provide
a basis for the development of more site-speciﬁc carrier systems.
However, endosomes formed after clathrin-mediated endocytosis
eventually fuse with lysosomes where degradation of the internalized
material occurs [56]. Hence, the advantage of site speciﬁcity is likely
opposed by a rather unfavorable intracellular fate of the peptide
micelles. The way in which the size of the particle and the peptide
surface density inﬂuence the recognition of cell surface constituents
and determine the uptake route remains to be examined in detail.
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